A Pivotal Phase 3 Trial to Evaluate BioChaperone Lispro (BC Lispro) in Europe and the U.S.
Latest Information Update: 15 Sep 2021
Price :
$35 *
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Adocia
- 07 Sep 2021 According to an Adocia media release, the preparatory work for the Phase 3 studies in the United States and Europe has been successfully completed and our commercial activities are aimed at finding a partner capable of financing the pivotal program through marketing authorization for these territories.
- 30 Jul 2020 According to an Adocia media release, the approvals by BfArM and the FDA ensure a clear path to initiate pivotal Phase 3 trial for BC Lispro in Europe and the U.S. following a successful comparative study (CTP 325471).
- 24 Jul 2020 New trial record